Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ophthalmologe ; 104(6): 505-7, 2007 Jun.
Artigo em Alemão | MEDLINE | ID: mdl-17334744

RESUMO

We report the case of a premature newborn (gestational age 33 weeks) with congenital glaucoma. After a trabeculotomy high intraocular pressure persisted, leading to adjuvant treatment with timolol and--when the infant was 3 weeks old--with brimonidine. After the first application of topical brimonidine the infant developed such severe apnoeic spells that intubation and temporary ventilation were necessary. A review of the literature reveals that when used in young infants brimonidine eye drops can potentially have toxic effects on the central nervous system (e.g. respiratory depression). The use of topical brimonidine is therefore not advised in this age group.


Assuntos
Anti-Hipertensivos/toxicidade , Glaucoma/congênito , Doenças do Prematuro/tratamento farmacológico , Síndromes Neurotóxicas/diagnóstico , Quinoxalinas/toxicidade , Insuficiência Respiratória/induzido quimicamente , Anti-Hipertensivos/administração & dosagem , Apneia/induzido quimicamente , Tartarato de Brimonidina , Catarata/congênito , Feminino , Glaucoma/tratamento farmacológico , Glaucoma/cirurgia , Humanos , Recém-Nascido , Soluções Oftálmicas , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/tratamento farmacológico , Quinoxalinas/administração & dosagem , Insuficiência Respiratória/diagnóstico , Trabeculectomia
2.
Crit Care Med ; 29(3): 645-51, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11373437

RESUMO

OBJECTIVE: To compare the efficacy of single, multiple, and continuous application of perfluorocarbon (PFC) FC-77 on gas exchange and lung pathology in a prolonged 24-hr study. DESIGN: Controlled animal trial. SETTING: Research laboratory in a university setting. SUBJECTS: Twenty-one newborn piglets (mean weight 1.94 kg). INTERVENTIONS: After intubation and instrumentation, the anesthetized animals were randomized in three groups: a) animals receiving one 1-hr session of partial liquid ventilation (PLV) followed by 23 hrs of conventional ventilation (CV), designated as the single PLV (S-PLV) group; b) animals receiving multiple 1-hr sessions of PLV with intermittent CV, designated as the multiple PLV (M-PLV) group; and c) animals receiving continuous PLV over 24 hrs, designated as the continuous PLV (C-PLV) group. After lung injury was induced with repeated saline lavage, specific ventilatory treatment was initiated. The oxygenation index, Pao2/Fio2 ratio, and ventilatory efficacy index were determined before and after lung injury and during the 24-hr course. After 24 hrs, the lungs were removed for histopathologic examination. MEASUREMENTS AND MAIN RESULTS: Gas exchange variables improved within 60 mins in all groups after the initiation of the specific ventilatory treatment (p < .01). The best outcome was observed in the C-PLV group, which provided a continuously stable gas exchange over the 24-hr period. S-PLV initially improved gas exchange, but after 6 hrs all variables were impaired when compared with C-PLV (p < .01). M-PLV transiently improved gas exchange variables after each PFC application; however, M-PLV was associated with a significant deterioration of all pulmonary variables during the 24-hr course. The lungs of the animals in the M-PLV group demonstrated an increased lung injury score (p < .01) and increased morphometric values (p < .05) when compared with C-PLV. CONCLUSIONS: In surfactant deficient lungs, single and multiple applications of PFC only transiently improved oxygenation. Multiple PFC fillings with intermittent gas ventilation led to a deterioration of gas exchange during the 24-hr study and severe lung damage. Continuous PLV provides the best gas exchange and the most favorable histopathologic outcome.


Assuntos
Modelos Animais de Doenças , Fluorocarbonos/uso terapêutico , Ventilação Líquida/métodos , Troca Gasosa Pulmonar/efeitos dos fármacos , Surfactantes Pulmonares/deficiência , Síndrome do Desconforto Respiratório do Recém-Nascido/patologia , Síndrome do Desconforto Respiratório do Recém-Nascido/terapia , Animais , Animais Recém-Nascidos , Gasometria , Fluorocarbonos/química , Fluorocarbonos/farmacologia , Humanos , Recém-Nascido , Ventilação Líquida/efeitos adversos , Masculino , Oxigênio/sangue , Distribuição Aleatória , Síndrome do Desconforto Respiratório do Recém-Nascido/etiologia , Síndrome do Desconforto Respiratório do Recém-Nascido/metabolismo , Síndrome do Desconforto Respiratório do Recém-Nascido/fisiopatologia , Cloreto de Sódio , Suínos , Irrigação Terapêutica , Fatores de Tempo , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...